Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease

Journal of Neurology

Volumn 254, Issue 8, 2007, Pages 1037-1043

  Happe, Svenja ^a   Baier, Paul Christian ^a   Helmschmied, Kathrin ^a   Meller, Johannes ^a   Tatsch, Klaus ^b   Paulus, Walter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dopamine transporter; Epworth sleepiness scale (ESS); Parkinson's disease; Sleepiness; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE; IOFLUPANE I 123; LEVODOPA; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BINDING AFFINITY; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DAYTIME SOMNOLENCE; DEPRESSION INVENTORY; DISEASE ASSOCIATION; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SELF CONCEPT; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATONIGRAL DEGENERATION; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; CORPUS STRIATUM; DISORDERS OF EXCESSIVE SOMNOLENCE; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 34548442066     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0483-6     Document Type: Article

References (29)

1. Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11:512-519
2. Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, Curb JD, Petrovich H (2005) Excessive daytime sleepiness and subsequent development of Parkinson's disease. Neurology 65:1442-1446
3. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52:1908-1910
4. Happe S, Trenkwalder C (2005) Sleep disorders in Parkinson's disease. In: Ebadi M, Pfeiffer R (eds) Parkinson's disease. CRC Press LLC, Boca Raton, USA, pp 217-227
5. Ryan M, Slevin JD, Wells A (2000) Non-ergot dopamine agonist-induced sleep attacks. Pharmacotherapy 20:724-726
6. Happe S, Berger K (2001) The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease. a prospective study. J Neurol 248:1062-1067
7. Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR (2001) A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 108:71-77
8. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58:1019-1024
9. Braak H, Rüb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536
10. Del Tredici K, Rüb U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson's disease pathology begin in the brain? Neuropathol Exp Neurol 61:413-426
11. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
12. Gibb WR, Lees AJ (1988) The relevance of Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
14. Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57:1497-1499
15. Hoehn MM, Yahr MD (1967) Parkinsonism; onset, progression and mortality. Neurology 17:427-467
16. Fahn S, Elton RL and members of the UPDRS development committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Lieberman A (eds) Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan Health Care Information, pp 153-163
17. Koch W, Radau PE, Hamann C, Tatsch K (2005) Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 46:1109-1118
18. Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Högl B, Trenkwalder C (2002) The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 73:629-633
19. Zung WWK (1972) The depression status inventory: an adjunct to the selfrating depression scale. J Clin Psychol 28:539-543
20. Klawans HL, Goetz C, Nausieda PA, Weiner WJ (1977) Levodopa-induced dopamine receptor hypersensitivity. Trans Am Neurol Assoc 102:80-83
21. Kaasinen V, Aalto S, Någren K, Hietala J, Sonninen P, Rinne JO (2003) Extrastriatal dopamine D2 receptors in Parkinson's disease: a longitudinal study. J Neural Transm 110:591-601
22. Kaasinen V, Någren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO (2000) Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease. Neurology 54:1482-1484
23. Baier PC, Branisa P, Koch R, Schindehütte J, Paulus W, Trenkwalder S (2006) Circadian distribution of motoractivity in unilaterally 6-hydroxydopamine lesioned rats. Exp Brain Res 169:283-288
24. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K (2000) Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder. Comparison with Parkinson's disease and controls. Brain 123:1155-1160
25. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, Trenkwalder C, Schwarz J, Noachtar S (2003) Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 26:507-512
26. Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG (2000) Correlation of Parkinson's disease severity and duration with 123IFP-CIT SPECT striatal uptake. Mov Disord 15:692-698
27. 123I]IPT and single-photon emission tomography. Eur J Nucl Med 24:415-421
28. Rye DB (2006) Excessive daytime sleepiness and unintended sleep in Parkinson's disease. Curr Neurol Neurosci Rep 6:169-176
29. Romiti A, Brusa L, Marciani MG, Pierantozzi M, Placidi F, Izzi F, Sperli F, Testa F, Stanzione P (2005) Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. J Neurol Sci 228:7-10